Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram.
|Title||Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram.|
|Publication Type||Journal Article|
|Year of Publication||2010|
|Authors||Lavretsky, H, Siddarth P, Irwin MR|
|Journal||The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry|
|Date Published||2010 Feb|
|Keywords||Aged, Aged, 80 and over, Antidepressive Agents, Second-Generation, Anxiety, Caregivers, Citalopram, cognition, Cost of Illness, Dementia, Depression, Double-Blind Method, Female, Humans, Male, Middle Aged, Pilot Projects, Placebos, Quality of Life, Remission Induction, Resilience, Psychological, Stress, Psychological, Treatment Outcome|
This study examined the potential of an antidepressant drug, escitalopram, to improve depression, resilience to stress, and quality of life in family dementia caregivers in a randomized placebo-controlled double-blinded trial.
|Alternate Journal||Am J Geriatr Psychiatry|